Finding treatments faster for patients with pulmonary fibrosis: an introduction to REMAP-ILD.

Подписаться 1,1 тыс.

Просмотров 1,5 тыс.

50% 1

On the 1st of November 2022, we held a webinar to share an insight into REMAP-ILD with patients, family members and healthcare professionals.
This ground-breaking trial has the potential to test multiple treatments for pulmonary fibrosis - and find the most effective ones faster.
Learn more on our website: www.actionpf.o...

Опубликовано:

6 сен 2024

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист

Посмотреть позже

Комментарии : 3

@gillianmorgan7848 Год назад

Thank you for an informative and interesting video. I am starting my new trial on Dec 2nd. Dr. Michael Gibbons is my consultant at Exeter RD&E hospital. I have had IPF since Oct. 3013.

@malamahabeer5733 Год назад

Hi is this a new treatment for pulmonary fibrosis , and when will it be available for patients, I am from South Africa, thx

@actionforpulmonaryfibrosis4969 Год назад

REMAP-ILD is the name of an ambitious project to rapidly assess potential treatments for patients affected by lung scarring. The aim is to create a global platform to carry out clinical trials. The team will use a new approach in trial design that will enable multiple therapies to be assessed at the same time, which are known as Randomized, Embedded, Multifactorial, Adaptive Platform (REMAP) trials. Find out more here: www.actionpf.org/news/remap-ild-the-future-of-clinical-trials-in-pulmonary-fibrosis